Ontology highlight
ABSTRACT:
SUBMITTER: Zheng R
PROVIDER: S-EPMC10372478 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
Zheng Ruiqi R Weng Shuang S Xu Jianping J Li Zhuo Z Wang Yaru Y Aizimuaji Zulihumaer Z Ma Sheng S Zheng Linlin L Li Haiyang H Ying Wantao W Rong Weiqi W Xiao Ting T
Computational and structural biotechnology journal 20230705
As sorafenib is a first-line drug for treating advanced hepatocellular carcinoma, sorafenib resistance has historically attracted attention. However, most of this attention has been focused on a series of mechanisms related to drug resistance arising after sorafenib treatment. In this study, we used proteomic techniques to explore the potential mechanisms by which pretreatment factors affect sorafenib resistance. The degree of redundant pathway PI3K/AKT activation, biotransformation capacity, an ...[more]